Skip to main content
. 2021 Dec 14;11:23956. doi: 10.1038/s41598-021-03214-x

Figure 3.

Figure 3

RORs for Depression and Anxiety in VigiAccess, all ages. Reporting odds ratios relative to teriparatide as an active control were calculated for the frequencies of depression or anxiety as an adverse event in patients. The ranges depicted in the forest plot are indicative of 95% confidence intervals and the X-axis is presented in logarithmic scale.